12/13/2021
IVAL is now part of Discovery Life Sciences!
Welcome to the world’s largest hepatocyte inventory, the world’s largest commercial biospecimen inventory and unmatched biomarker and hepatocyte expertise to help you accelerate your drug development programs.
IVAL’s hepatocyte expertise and scale amplify Discovery’s leading biospecimen and biomarker services to jointly deliver meaningful answers that you can trust to develop innovative drugs and diagnostics faster and more cost-effectively.
Thank you to our community of clients and associates for their continued support and partnership. We are driven to provide innovative products and services, and are ready for this next chapter together.
Read more about the recent acquisition and Discovery’s new ADME, toxicology, and pharmacology solutions at the link below.
https://www.dls.com/press/discovery-life-sciences-acquires-in-vitro-admet-laboratories/